Introduction
T h e production of an extracellular polysaccharide capsule is a common feature of many bacteria [l].
T h e capsule, which often constitutes the outermost layer of the cell, mediates the interaction between the bacterium and its immediate environment and has a crucial role in the survival of bacteria in hostile environments. One such environment is the human host, where interactions between the capsule and the host's immune system can be vital in deciding the outcome of an infection [2, 3] . In the absence of specific antibody, a capsule offers protection against the non-specific arm of the host's immune system by conferring increased resistance to complement-mediated killing and complement-mediated opsonophagocytosis [2-4].
Owing to similarities to polysaccharide moieties present within the host, a small set of capsules are poorly immunogenic [5,6]. The Escherichia coli K1 and Neisseria meningitidis group B capsules, both of which contain N-acetylneuraminic acid, and the heparin-like E. coli K5 capsule all elicit a poor antibody response in infected individuals [7] and confer some measure of resistance to the host's adaptive humural response. Polysaccharide capsules can promote the formation of biofilms and the colonization of a variety of ecological niches, including indwelling catheters, prostheses and the formation of alginate-rich biofilms in the lungs of cystic fibrosis patients [8] . In such instances the Abbreviations used: HCA. hydrophobic cluster analysis: Kdo, 3-deoxy-~-manno-2-octuloson~c acid. 'To whom correspondence should be addressed.
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polysaccharide can present a permeability barrier to antibiotics and hinder the effective eradication of the bacteria [9].
Although the role of polysaccharide capsules in the disease process is well documented, there is an embarrassing lack of understanding at the molecular level about fundamental aspects of capsule production. T h e biosynthesis of capsular polysaccharides and their subsequent transport on to the cell surface provide a unique challenge to the bacterium. It must synthesize within the cell a large negatively charged macromolecule consisting of repeating subunits linked in a precise order. This macromolecule must then be transported to the cell surface where it is subsequently anchored. In Gram-negative bacteria, the export process involves the polysaccharide's traversing two membranes and the intervening periplasmic space. Understanding the mechanisms by which capsular polysaccharides are synthesized and transported to the cell surface could have profound implications for the development of novel therapeutic agents for the treatment of Gram-negative infections and the engineering of biomedically important glycoconjugates in E. coli.
Expression of €. coli capsules
T h e expression of E. coli capsules offers an experimentally tractable system in which to address questions about the synthesis, transport and assembly of extracellular polysaccharide capsules in Gram-negative pathogens. T h e identification of functionally conserved steps in the export of polysaccharide capsules in many Gram-negative Figure 1) [17]. T h e biosynthesis of the K5 polysaccharide involves four proteins, KfiA to KfiD, encoded by the serotypespecific region 2 of the K5 capsule gene cluster (Figure 2) [19]. Functions for these proteins in the biosynthesis of the K5 polysaccharide are beginning to emerge. Mutations in the kjiA and kfiB genes abolish endogenous K5 transferase activity and the production of any detectable polysaccharide [20]. However, the addition of exogenous K5 polysaccharide stimulates K5 trans-
Fb-1 Schematic representation of the Gcherichia coli K5 capsule assembly complex
The Kfi proteins involved in the specific biosynthesis of the K5 polysacchande are shaded The Kps proteins common t o all group II capsules are shown as open structures, the KpsE protein is shown as a dimer The membrane acceptor for the biosynthesis of the K5 polysacchande is depicted by a star, whereas the polysacchande is shown by a curly line The inner and outer membranes are labelled IM and OM respectively The local deformation ofthe outer membrane is depicted t o convey some form of trans-penplasmic complex, although there is no expenmental evidence for such a distortion in the outer membrane biosynthesis. No biochemical activity has been assigned to KfiB, although structural predictions would suggest that it is capable of forming a coiled-coil structure; it therefore might have a role in the formation and maintenance of the biosynthetic complex. Recently the KfiA protein has been demonstrated in vitro to have UDP-GlcNAc transferase activity (G. Griffiths, K. Lidholt and I. S. Roberts, unpublished work). One possibility is that KfiA is the glycosyltransferase that adds GlcNAc to the membrane acceptor, probably undecaprenol phosphate, and that this provides the substrate that is extended by the bifunctional glycosyltransferase KfiC, which adds alternating GlcA and GlcNAc residues from UDP-GlcA and UDP-GlcNAc to synthesize the K5 polysaccharide [18, 19] . This would be in keeping with the observation that KfiC alone cannot initiate K5 biosynthesis [18] . The fourth protein, KfiD, is a UDP-Glc dehydrogenase that catalyses the production of UDP-GlcA from UDP-Glc for K5 biosynthesis [19, 21] .
Recently we have embarked on a structurefunction analysis of the KfiC enzyme, which is a rare example of a bifunctional glycosyltransferase, with both a and Pglycosyltransferase activity. The catalytic mechanism of polysaccharide growth involves the formation of a glycosidic bond via the addition of sugars from UDP-sugar precursors to the growing polysaccharide chain. Depending on whether an a or P linkage is being formed, catalysis can take place either by an inversion mechanism in which a P-linked product is formed from the alinked U D P sugar or by a retaining mechanism in which an a-linked product is formed [22] . In the inversion reaction, a single nucleophilic substitution at the anomeric carbon atom of the UDPsugar will be sufficient to generate the P bond.
This will involve two acidic active site amino acids that act as acid-base catalysts, one of which acts as an acid catalyst to protonate the substrate while the second acts as a base catalyst to deprotonate a water molecule [22] . It is postulated that with Uglycosyltransferases the retaining mechanism is a two-step process in which two nucleophilic substitutions at the sugar anomeric carbon result in a linked product via a glycosyl-enzyme intermediate
Previously, hydrophobic cluster analysis (HCA) has been used successfully to predict regions of secondary-structure similarity between P-glycosyltransferases [23, 24] . HCA of processive P-glycosyltransferases, which add sugar residues to the reducing end of the polysaccharide molecule, have identified two conserved domains, A and B [23, 24] . In contrast, non-processive 8-glycosyltransferases, which add a single residue to the non-reducing end of the polysaccharide molecule, merely contain domain A [23, 24] . Domain A consists of four alternating P-strands separated by three a-helices. Two conserved aspartic residues are present in the C-terminal loops of the p2 and p4 strands and it has been suggested that these might be the catalytic amino acids for the nucleophilic substitution reaction [23, 24] . HCA of KfiC identified a domain A containing the two conserved aspartic residues in the p2 and P4 strands; this is in keeping with the activity of KfiC, which adds sugar residues to the non-reducing end of the K5 polysaccharide [19] . Site-directed mutagenesis combined with glycosyltransferase assays with the use of defined K5 oligosaccharides terminating with either GlcA or GlcNAc at their non-reducing end demonstrated that the conserved aspartic residues are the catalytic amino acids and that domain A is the P-GlcA transferase active site [18] . This was the first biochemical evidence for the role of these conserved aspartic residues in the catalysis of a-glycosyltransferase activity. A truncated derivative of KfiC, comprising the first 381 residues but deleted for the last 139 residues at the C-terminus, had no UDP-GlcA transferase ac- [32, 33] . Similarly it has been suggested that, in the To1 system for the uptake of colicins, the colicin itself might provide a bridge between its outer membrane receptor and periplasmic TolA protein [34] . Therefore the failure to demonstrate any interactions between KpsE and other Kps proteins involved in polysaccharide transport could reflect an interaction of KpsE with these proteins via the exported polysaccharide molecule, in which case formaldehyde cross-linking would not detect such interactions. Secondly, it is possible that KpsE interacts with the biosynthetic/transport complex on the inner membrane via its N-terminal membrane-spanning domain. Because formaldehyde cannot cross the inner membrane it would be unlikely to detect any such interactions.
Evidence for a 'capsule assembly complex'
It has long been suggested that capsular polysaccharide biosynthesis involves the formation of a biosynthetic complex on the inner membrane [ 12-1 41. Recently our laboratory has generated the first evidence that such a hetero-oligomeric complex is formed on the inner membrane, comprising proteins involved in polysaccharide biosynthesis and transport [17] . The formation of the complex is dependent on the KpsC, M, S and T proteins, which are necessary for the biosynthetic proteins KfiA to KfiD to become associated with the inner membrane and generate a functional biosynthetic complex [17] . capsules suggests that they might have a general role in the assembly of group I1 biosynthetic complexes in E. coli. T h e formation of such a multiprotein complex on the inner membrane permits the initiation of polysaccharide biosynthesis, polysaccharide extension, the addition of PAKdo and polysaccharide export to be co-ordinated spatially at one site. In addition, complex formation could improve the efficiency of polysaccharide biosynthesis by increasing the effective concentrations of the necessary proteins at the site of polymer synthesis. It would be logical if the terminal stages in the export pathway involving KpsE and D were linked to the biosynthetic/export complex in the inner membrane, to form a multi-protein 'capsule assembly complex' that straddles the periplasm and interacts with both the inner and outer membranes (Figure 1) [14,17] . In such a model there would be a direct continuum between the cytoplasm and the cell surface (Figure l ) , which could facilitate the transport of capsular polysaccharides to the cell surface. T h e observation that osmotic shock releases certain cytoplasmic components of the biosynthetic/transport complex into the periplasm [17], which is a characteristic of complexes that are associated with areas of adhesion between the inner and outer membranes, would support the concept of a periplasm-spanning capsule assembly complex. In addition, there is now increasing evidence for trans-periplasmic multiprotein transport complexes that bridge between the inner and outer membranes; the best characterized so far are the To1 and Ton transport systems [35] and the type I (ABC) secretion pathway [33] .
Conclusions
Studies so far on the expression of the E. coli K5 capsule have begun to shed light on the biosynthesis and export of group I1 capsules in E.
coli. There is now convincing evidence that the biosynthesis and export of these molecules are achieved by a multi-protein complex that, as a consequence of these processes, can deform the local membrane architecture. T h e challenge now facing us is to dissect out the protein-protein and
I
Glycobiology of Pathogen-Host Interactions protein-polysaccharide interactions that mediate the biosynthesis and export of these macromolecules so as to understand these processes at the molecular level. 
Introduction
T h e cell wall of fungi remains an unexploited target for clinically effective antifungal drugs. This is disappointing in that the wall material is composed almost exclusively of components that are absent from human cells. Moreover, the activities of many of the major biosynthetic enzymes are known to be essential for growth and viability, so the wall is a ideal candidate for fungicidal drugs that should have low toxicity. T h e chemical composition of the wall varies substantially between different fungi ; however, it consists mainly of the polysaccharides chitin and glucan, and proteins that are glycosylated with short-chain or high-molecular-mass mannan. In most fungi the outer cell wall layer is particularly enriched in mannoproteins, which can constitute 50 yo of the overall dry weight of the wall. The structural polysaccharides, mainly p-1,3 and p-1,6 glucan and chitin, are covalently linked to each other and to the mannoproteins either directly or via glycosylphosphatidylinositol-anchors [ 1,2]. Together these materials form a skeletal matrix that is supportive enough to resist cell turgor pressure yet is compliant at the sites of wall expansion. Although higher eukaryotes lack chitin, glucan and mannan, the potential for antifungal chemotherapy targeted against wall biosynthetic enzymes has yet to be realized. Future efforts in this direction will be facilitated through an in-depth analysis of genes encoding critical and essential biosynthetic processes. For example, the individual genes in a multigene family can be assessed for their relative importance for cell viability by examining strains in which one or more genes have been eliminated by targeted gene disruption [3] .
For human pathogenic fungi such as Candida albicans, the outer cell wall has a critical role in its interactions with the host. Because this layer is enriched for mannoproteins, these molecules are critical for the biology and pathogenesis of this fungus. T h e cell wall is the point of contact with epithelia and endothelia and is therefore critical in adhesion and host colonization [4]. Mannoproteins are major antigens and a molecular shield against defensive enzymes in the host. They can also function in modulating and avoiding surveillance by the immune system [5]. T h e nature of the mannoproteins on the cell surface is dynamic and changing [6] , suggesting that antigenic variation at the level of regulated mannoprotein gene expression might be part of the mechanism of avoiding immune capture. Interestingly, most of the hyphal-specific genes that have been recognized so far encode cell wall mannoproteins [6-91. Therefore there is good reason to pay particular attention to the analysis of cell wall proteins and the process of glycosylation in the context of Candida morphogenesis and pathogenesis.
Candida antigens have been the subject of fairly extensive study for many years ; however, the analysis of mannosylation at the genetic level is a recent activity. This area is facilitated by detailed analyses of the genetics and biochemistry of glycosylation in Saccharomyces cerevisiae [ 10,111, which provides a resource for the understanding of underlying pathways and for the isolation of homologous genes. However, glycosylation in Candida has its own context because it provides a direct route for investigations of fungal pathogenesis and host-fungus interactions. T h e goal of our research is (1) to investigate the role of particular oligosaccharidic linkages in Candidahost interactions through an analysis of defined null mutants in 0-and N-linked mannosylation and (2) to discover key enzyme activities that might constitute novel therapeutic targets.
